Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
Fig 5
Recipient derived cells present in several cellular subsets in mixed chimerism patients.
Each graph depicts percentages of chimerism for different cell subsets for each mixed chimerism (MC, n = 9) patient. Chimerism was analysed for T-cells (CD3+), CD4+ T-cells, CD8+ T-cells, B-cells (CD19+ CD3-), NK-cells (CD56+ CD3-), myeloid cells (CD33+) and TCRγδ+ T-cells. A black column represents the percentage of recipient derived cells, while the white column represents donor derived cells. ND depicts the subsets where chimerism analysis was unsuccessful due to insufficient DNA.